Theme: Harnessing the Global Innovations in vaccines, Therapeutics and Healthcare for the better future

Global Vaccines Congress 2017
Past Report of Vaccines 2016

Global Vaccines Congress 2017

Sessions/Tracks

Conference series LLC invites all the participants from all over the world to attend “World Congress on Vaccines & Therapeutics: Travel Medicine For Infectious Diseases” which will be held during October 05-06, 2017 Chicago, USA, which includes Prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of the conference is "Harnessing the Global Innovations in vaccines, Therapeutics and Healthcare for the better future".

Global Vaccines Congress 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their Travel Medicine and Vaccines or its sister publication Immunome Research. Conference series LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Track: 1 Infectious Diseases Types

The Diseases caused by germs and which may infect any part of the body are called Infectious Diseases. They can spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

With the burgeoning response and grand success of Conference series LLC" takes the pride of announcing the grand commencement of International Conference on Travel Medicine & Vaccines scheduled during October 05-06, 2017 Chicago, USA.

Track: 2 Ebola, Arboviral diseases and Haemorrhagic Fever

Nine of the people contracted the disease outside the US and travelled into the country, either as regular airline passengers or as medical evacuees; of those nine, two died. Two people have contracted Ebola in the United States; both were nurses who treated an Ebola patient; both have recovered.Arbovirus is a term used to refer to a group of viruses that are transmitted by arthropod vectors. The word arbovirus is an acronym (ARthropod-BOrne virus).Symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last 3 or 4 days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and hemorrhagic fever may also occur.The word tibovirus (TIck-BOrne virus) is sometimes used to describe viruses transmitted by ticks, a superorder within the arthropods.

Track: 3  Business People Investment Meet

Entrepreneur is the organize of starting a business, typically a start-up company offering an innovative product, process or service. The entrepreneur perceives an promotion and often exhibits biases in taking the decision to exploit the opportunity. The exploitation of entrepreneurial  a chance for promotion includes design actions  develop a business plan, acquire the human, financial other required resources, and  be responsible for its success or failure. Entrepreneurship may operate within entrepreneurship ecosystem which includes government programs and services that promotes entrepreneurs, entrepreneurship resource In recent years, "entrepreneurship" has been extended from its origins in for-profit businesses to include social entrepreneurship the concept of the political entrepreneur.

Track: 4 Immunization for Emerging and Communicable Diseases

Immunization is one of the most successful and cost-effective health interventions, preventing millions of deaths every year. From infants to seniors, immunization protects against diseases such as diphtheria, measles, pertussis, pneumonia, polio, rotavirus, rubella and tetanus. The benefits of immunization are increasingly being extended to adolescents and adults, providing protection against life-threatening diseases such as influenza, meningitis, and cancers. A communicable disease is one that is spread from one person to another through a variety of ways that include: contact with blood and bodily fluids; breathing in an airborne virus; or by being bitten by an insect.

Track: 5 Global policy/Regulations for Disease prevention and control

To prevent or reduce the burden of infectious diseases of public health importance. There is reduced incidence of infectious diseases of public health importance. There is reduced morbidity and mortality associated with infectious diseases of public health importance. There is increased public capacity to prevent and control infectious diseases. There is increased capacity on the part of all hospitals, long-term care homes (LTCHs), and other settings with risk of infections to prevent and control infectious diseases.

Track: 6  Global Trends in Emerging Infectious Diseases

An Infectious Disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance and public health issues due to unhygienic conditions.

Track: 7 Animal and Tick-borne Infections

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. Tick-borne illnesses are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. Because individual ticks can harbour more than one disease-causing agent, patients can be infected with more than one pathogen at the same time, compounding the difficulty in diagnosis and treatment. Currently (2015), there are 16 known tick-borne diseases of humans (four discovered since 2013). As the incidence of tick-borne illnesses increases and the geographic areas in which they are found expand, it becomes increasingly important that health workers be able to distinguish the diverse, and often overlapping, clinical presentations of these diseases.

Track: 8 Vaccines Against infectious & Non Infections diseases

Infection is the invasion of an organism's body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to these organisms and the toxins they produce. Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection. using their immune system. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response.Among the vast varieties of microorganisms, relatively few cause disease in otherwise healthy individuals. Infectious disease results from the interplay between those few pathogens and the defenses of the hosts they infect. The appearance and severity of disease resulting from any pathogen, depends upon the ability of that pathogen to damage the host as well as the ability of the host to resist the pathogen.

Track: 9 Allergies and skin diseases - Vaccinations

Skin problems are among the most frequent medical problems in returned travellers. The largest case series of dermatologic problems in returned travellers from the Geo Sentinel Surveillance Network showed that cutaneous larva migrans, insect bites, and bacterial infections were the most frequent skin problems in ill travellers who sought medical care, making up 30% of the 4,742 diagnoses In another review of 165 travellers who returned to France with skin problems, cellulitis, scabies, and pyoderma led the list of skin conditions. These data are biased in that they do not include skin problems that were diagnosed and, in many cases, easily managed during travel or that were self-limited.

Track: 10 Malaria sickness in and Treatment

Malaria is caused by the protozoan parasite Plasmodium. Human malaria is caused by four different species of Plasmodium: P. falciparum, P. malaria, P. ovale and P. vivax. Humans occasionally become infected with Plasmodium species that normally infect animals, such as P. knowlesi. As yet, there are no reports of human-mosquitohuman transmission of such “zoonotic” forms of malaria. The malaria parasite is transmitted by female Anopheles mosquitoes, which bite mainly between dusk and dawn. Malaria is an acute febrile illness with incubation period of 7 days or longer. Thus, a febrile illness developing less than 1 week after the first possible exposure is not malaria.

Track: 11 Diarrhea and other Gastrointestinal Disorders

sometimes tourist diarrhoea or traveller’s dysentery, is a stomach and intestinal infection, and the most common illness affecting travellers. It is defined as three or more unformed stools passed by a traveller within a 24-hour period. It is commonly accompanied by abdominal cramps, nausea, and bloating. The diagnosis does not imply causative organism, but enter toxigenic Escherichia coli (ETEC) is the most common pathogen Bacteria are responsible for roughly 80% of cases; most of the rest are caused by viruses and protozoans. Although most travellers with TD recover within a few days with little or no treatment, symptoms can sometimes be severe enough to require medical intervention. In those who are immunocompromised or otherwise prone to serious infections, TD is a significant concern and occasionally even life-threatening.

Track: 12 Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called Mycobacterium tuberculosis which spread through the lymph nodes and bloodstream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine, and brain.

Track: 13 Rubella Vaccines

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated.

Track: 14  Global Market on Infectious Diseases

Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Track: 15 Causes and Symptoms of Infectious Diseases

Infectious Diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

 

 





About Conference

Conference Series LLC Conferences invites all the participants from all over the world to attend “International Conference on Vaccines, Therapeutics &Travel Medicine For Infectious Diseases” during October 05-06, 2017 Chicago, USA . which includes explicit Keynote presentations, plenary talks from highly distinguished scientific staff, Poster presentations from talented student communities from Universities and Research labs and Exhibitions from Industries and companies in the vaccine and pharmaceutical sectors.

With the burgeoning response and grand success of Conferenceseries LLC "5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" held on July 27-28, 2015 in Brisbane, Australia,  This will be the latest in the OMICS International annual vaccine meeting series with 500+ Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas & establish business and research collaborations. Opportunities are there for the reseachers present at the meeting to publish their manuscripts/full-length papers based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. OMICS International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ upcoming and previous symposiums and workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccine community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies




Market Analysis





Past Conferences

Vaccines 2016 report

Sensing the raising importance of Vaccines, Conference series LLC International hosted the 

26th International Conference on Travel Medicine, Vaccines & Therapeutics, scheduled from October 05-06, 2017, in Chicago, USA with a theme “Harnessing the Global Innovations in vaccines, Therapeutics and Healthcare for the better future”.  Benevolent response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Infectious Diseases Types
  • Ebola, Arboviral diseases and Haemorrhagic Fever
  • Causes and Symptoms of Infectious Diseases
  • Business People Investment Meet
  • Immunization for Emerging and Communicable Diseases
  • Global policy/Regulations for Disease prevention and control
  • Global Trends in Emerging Infectious Diseases
  • Global Market on Infectious Diseases
  • Animal and Tick-borne Infections
  • Vaccines Against infectious & Non Infections diseases
  • Allergies and skin diseases in Traveller - Vaccinations
  • Malaria sickness in and Treatment
  • Diarrhea and other Gastrointestinal Disorders
  • Rubella Vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Magdalena Tary-Lehmann, Case Western Reserve University School of Medicine, USA

Jorge Alberto Panameno Pineda, Fundación Salvadoreña para la Inmunoinfectologia y

Medicina Tropical, USA

Giulio Filippo Tarro Foundation de Beaumont Bonelli for Cancer Research, Italy

Kei Numazaki, International University of Health and Welfare, Japan

Michele Stone, University of Maryland, USA

ConferenceSeries LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced  in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Global Vaccines Congress 2016, is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 26th International Conference on Travel Medicine, Vaccines & Therapeutics”October 05-06, 2017 Chicago, USA.

Keynote Forum

Tracks

Posters&Accepted Abstracts

 

Vaccines Asia Pacific-2015
 

 Sensing the raising importance of Vaccines, Conference series LLC International hosted the 5th Asiapacific Global Summit and Expo on Vaccines & Vaccination” (Vaccines Asiapacific-2015), scheduled from July 27-29, 2015 in Brisbane, Australia with a theme “Vaccine Research: From Bench to Bedside”.  Benevolent response and active participation was received from the Editorial Board Members of Conference Series LLC Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Technologies for the Design, Discovery, formulation and administration of vaccines.
  • Developing Next-Gen Conjugate Vaccines.
  • New trends in carbohydrate-based vaccines.
  • Vaccines for Pregnant Women.
  • Recent advances in animal vaccination
  • Adjuvants for human vaccines—current status, problems and future prospects.
  • Current developments in bacterial conjugate vaccines potency.
  • Recent trends in attenuated vaccines.
  • Advancements in vaccine development
  • Vaccination and quality of life
  • Protein subunits- vaccination.
  • Toxoid vaccines and its importance
  • Geriatric Immunization
  • Vaccines under research and development, major diseases
  • Innovative development of vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Nikolai Petrovsky, Flinders University, Australia

Dr. Roy Hall, The University of Queensland, Australia

Dr. Jan Fohlman, Växjö and Uppsala University, Sweden

Dr. Istvan Toth, The University of Queensland, Australia

Young Researchers:

Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered nanoliposomes against Group A streptococcus

Nirmal Marasini, The University of Queensland, Australia

Title: A Protective Immune Response Using Asymmetric Multi-Epitope Self-Adjuvanting lipopeptide Vaccine Model

Sharareh Eskandari, The University of Queensland, Australia

Title: Binding and immune modulation properties of mannosylated lipo-peptide vaccines

Bita Sedaghat, The University of Queensland, Australia

Title: Liposomes as a Delivery Platform of Vaccines Against Group A Streptoccocus

Khairunnisa Abdul Ghaffar, University of Queensland, Australia

            ConferenceSeries LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced  in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Asiapacific-2015, is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" to be held during October 17-19, 2016 Kuala Lumpur, Malaysia.

Keynote Forum

Tracks

Posters&Accepted Abstracts

 For More details: http://vaccines.global-summit.com/asia-pacific/2015/

Vaccines 2014 report

The 4th International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS International. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

Overview

http://www.conferenceseries.com/immunology-conferences.php

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination

• Novel Delivery technologies in Vaccines and many more...

The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

Jeffrey B Ulmer, Novartis Vaccines USA

Ray Spier, Former President, International Society for Vaccines, UK

Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.

All accepted abstracts have been indexed in OMICS International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

Sponsors and exhibitors

Sanofi Pasteur SA

U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370

Vaccinogen Inc.,

5300 West view Dr # 406, Frederick, MD 21703, United States

Cellular Technology Limited (CTL)

North & South America

CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,

Gen Phar

600 Seacoast Pkwy # 100,

Mt Pleasant, SC 29464, United States

Vaccines-2013 Report

OMICS International, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by OMICS International, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.

 Highlights of Annual Global Vaccines Conferences-OMICS International

 • Keynote forum

• Exhibitions

• Company Presentations

• Speaker Forum

• Workshops and Symposia’s

• B2B Meetings

• One to One meeting

• Special Session for Students

• Scientific writing

• Journal review

• Grant writing

• Strategies for building a scientific career

• Scientific careers outside of research

• Company Promotions

• Young Research Forum

• Best Poster Awards

• Certification by the “International Organizing committee” and many more... 

Vaccines-2012 Report

The 2nd International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from OMICS International. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following

 Scientific tracks:

• Vaccines and the Basic Immune System

• New Approaches for B and T Cells

• Cellular and Molecular-Based Vaccines

• Vaccines Against Infectious Diseases

• Manufacturing, Production and Development of Vaccines

• Regulatory and Ethical Issues of Vaccines and Public Acceptance

• Current Issues on Clinical Evaluation and Field Trials of Vaccines

• Modern Technologies in Vaccine Discovery and Development

• Age-Specific Immune Response to Vaccination and many more...

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 300 attendies representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included

 De-Chu Christopher Vaxin Inc., USA

John Dong GenPhar, USA

Donald E. Greydanus Western Michigan University School of Medicine, USA

Eli Young OpSaniTx, USA

Takashi Kei Kishimoto Selecta Biosciences, USA

Daniel H Zimmerman CEL-SCI Corporation, USA

Gerardo Kaplan FDA, USA

Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA

Haval Shirwan University of Louisville, USA and many more.

All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.All accepted abstracts have been indexed in OMICS International- Journal of Vaccines & Vaccination as a specialissue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.

Vaccines-2011 Conference Report

The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November

22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by OMICS Group brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.

Conference highlighted the following topics:

• Vaccines and the basic immune system

• New approaches for B and T cells

• Cellular and molecular-based vaccines

• Vaccines against infectious diseases

• Therapeutic vaccine manufacturing, production and development

• Logical and ethical issues and vaccines

• Experimental and clinical evaluation of therapeutic vaccines

• Basic Vaccinology and modern vaccine discovery technologies and many more...

The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with

aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and

strategies of Vaccines and Vaccination.

We take an immense pleasure in thanking our Keynote Speakers:

Gary Alan Flory Virginia Department of Environmental Quality, USA

Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA

Kei Amemiya US Army Medical Research Institute, USA

Edmund J. Gosselin Albany Medical College, USA

Mansour Mohamadzadeh University of Florida, USA and many more...

Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.

 Conference Proceedings

Keynote speakers

Scientific Tracks

Posters

Accepted Abstracts

We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the overwhelming response and suggestions and feedbacks from our previous attendees. OMICS International is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.





Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 05-06, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
travelmedicine@vaccineconferences.com
Sponsors / Exhibiting / Advertising.
General Queries.

Highlights from last year’s Convention!

Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.